[Strontium ranelate].
Strontium ranelate, which has dual effects of decreasing bone resorption and increasing bone formation, is a new orally active drug to treat osteoporosis. Although the clinical values are scientifically proved and the governments admit as one of the treatment for osteoporosis in many countries, the clinical trial is still undergoing in Japan.